Lenacapavir, an HIV-prevention injection offering six months of protection, will be available from January 2026 at a cost of approximately Sh6,000 per...
The injectable drug, approved by the US Food and Drug Administration in June 2025 and added to updated World Health Organisatio guidelines in July 202...
The Registrar said the approval allows for the reservation of the party name for a maximum of 90 days from the date of the correspondence.
Stay ahead of the news! Click ‘Yes, Thanks’ to receive breaking stories and exclusive updates directly to your device. Be the first to know what’s happening.